spacer
home > ict > autumn 2016 > can you resist?
PUBLICATIONS
International Clinical Trials

Can You Resist?

Alexander Fleming – who is credited with creating the first antibiotic, penicillin, in 1928 – cautioned as long ago as 1945: “There is the danger that the ignorant man may easily underdose himself and by exposing his microbes to nonlethal quantities of the drug make them resistant.” The O’Neill Commission on anti-microbial resistance (AMR) reported in 2015 that if we fail to act on AMR, then an additional 10 million lives would be lost each year to drugresistant strains of certain bacterial infections by 2050, at a cost to the world economy of $100 trillion.

In September, 193 UN member states agreed to combat the proliferation of drug-resistant infections, currently estimated to kill more than 700,000 people each year. At the 68th World Health Assembly in May 2015, a global action plan to tackle AMR was endorsed. To achieve the aforementioned goal, it set out five strategic objectives:
  • To improve awareness and understanding of AMR
  • To strengthen knowledge through surveillance and research
  • To reduce the incidence of infection • To optimise the use of antimicrobial agents
  • To develop the economic case for sustainable investment that takes into account the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions
By contrast, an analysis released in November last year by the Tufts Centre for the Study of Drug Development estimated the average cost to produce a medication as about $2.6 billion, taking 10-15 years to accomplish. As I have previously remarked, there is little incentive for businesses to develop new antibiotics, since their use will be restricted so that resistance will not be built up. As an example, by 2013, the number of international pharmaceutical companies developing antibiotics had dwindled to just four.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Graham Hughes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

 
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement